back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2023-01-26 11:46 Tx date 2023-01-25 |
$LOVE
Cannara Biotech Inc. |
Krivorot, Zohar
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Javaa Private Equity Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$21,000
+200,000 vol $0.105 each |
242,367,820 | |
| Filed 2022-12-12 17:24 Tx date 2022-09-29 |
$LOVE
Cannara Biotech Inc. |
Sherman, Brian
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
50 - Grant of options
|
$22,500
+125,000 vol $0.18 each |
1,143,700 | |
| Filed 2022-12-12 17:17 Tx date 2021-12-07 |
$LOVE
Cannara Biotech Inc. |
Sherman, Brian
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
50 - Grant of options
|
$180,000
+1,000,000 vol $0.18 each |
1,000,000 | |
| Filed 2022-12-12 17:11 Tx date 2022-11-30 |
$LOVE
Cannara Biotech Inc. |
Sherman, Brian
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,563
+23,300 vol $0.11 each |
1,167,000 | |
| Filed 2022-12-12 17:10 Tx date 2022-08-02 |
$LOVE
Cannara Biotech Inc. |
Sherman, Brian
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,980
+18,000 vol $0.11 each |
1,018,700 | |
| Filed 2022-12-12 17:09 Tx date 2022-01-26 |
$LOVE
Cannara Biotech Inc. |
Sherman, Brian
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$94.50
+700 vol $0.135 each |
1,000,700 | |
| Filed 2022-12-12 17:07 Tx date 2021-10-04 |
$LOVE
Cannara Biotech Inc. |
Sherman, Brian
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-12-12 13:51 Tx date 2022-09-29 |
$LOVE
Cannara Biotech Inc. |
Krivorot, Avi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
$22,500
+125,000 vol $0.18 each |
325,000 | |
| Filed 2022-12-01 23:52 Tx date 2022-11-30 |
$LOVE
Cannara Biotech Inc. |
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$24,970
+227,000 vol $0.11 each |
2,097,950 | |
| Filed 2022-11-30 17:03 Tx date 2022-11-30 |
$LOVE
Cannara Biotech Inc. |
Stern, Derek Elan
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$116,800
+1,000,000 vol $0.1168 each |
11,720,000 | |
| Filed 2022-11-29 15:35 Tx date 2022-08-14 |
$LOVE
Cannara Biotech Inc. |
Landry, France
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: France Landry (Indirect Ownership)
|
Options
50 - Grant of options
|
+250,000 vol |
500,003 | |
| Filed 2022-11-29 15:25 Tx date 2022-08-14 |
$LOVE
Cannara Biotech Inc. |
Landry, France
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: France Landry (Indirect Ownership)
|
Options
50 - Grant of options
|
+156,000 vol |
250,003 | |
| Filed 2022-11-29 15:23 Tx date 2022-08-14 |
$LOVE
Cannara Biotech Inc. |
Landry, France
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: France Landry (Indirect Ownership)
|
Options
50 - Grant of options
|
+94,000 vol |
94,003 | |
| Filed 2022-11-29 15:14 Tx date 2022-08-14 |
$LOVE
Cannara Biotech Inc. |
Landry, France
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: France Landry (Indirect Ownership)
|
Options
00 - Opening Balance-Initial SEDI Report
|
3 | ||
| Filed 2022-11-09 08:22 Tx date 2022-09-29 |
$LOVE
Cannara Biotech Inc. |
Olds, Donald John
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$22,500
+125,000 vol $0.18 each |
500,000 | |
| Filed 2022-11-07 15:08 Tx date 2022-09-29 |
$LOVE
Cannara Biotech Inc. |
BEN MOUSSA, ISSAM EDDINE
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
250,000 | ||
| Filed 2022-10-31 09:59 Tx date 2022-09-29 |
$LOVE
Cannara Biotech Inc. |
Manouk, Anthony
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$22,500
+125,000 vol $0.18 each |
1,625,000 | |
| Filed 2022-10-22 21:41 Tx date 2022-09-29 |
$LOVE
Cannara Biotech Inc. |
Durocher, Mary
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$9,000
+50,000 vol $0.18 each |
300,000 | |
| Filed 2022-10-22 21:39 Tx date 2022-09-29 |
$LOVE
Cannara Biotech Inc. |
Durocher, Mary
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$9,000
+50,000 vol $0.18 each |
250,000 | |
| Filed 2022-10-10 14:59 Tx date 2022-09-29 |
$LOVE
Cannara Biotech Inc. |
Dupuis, Nicolas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+125,000 vol |
1,275,000 | |
| Filed 2022-10-05 17:49 Tx date 2022-09-29 |
$LOVE
Cannara Biotech Inc. |
Follain, Noemi
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$22,500
+125,000 vol $0.18 each |
1,625,000 | |
| Filed 2022-09-30 16:11 Tx date 2022-09-29 |
$LOVE
Cannara Biotech Inc. |
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$2,250,000
+12,500,000 vol $0.18 each |
26,000,000 | |
| Filed 2022-09-30 16:04 Tx date 2022-09-29 |
$LOVE
Cannara Biotech Inc. |
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$750,000
+7,500,000 vol $0.10 each |
13,500,000 | |
| Filed 2022-09-02 16:08 Tx date 2022-08-31 |
$LOVE
Cannara Biotech Inc. |
Stern, Derek Elan
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$80,640
+720,000 vol $0.112 each |
10,720,000 | |
| Filed 2022-08-24 10:20 Tx date 2022-08-23 |
$LOVE
Cannara Biotech Inc. |
Olds, Donald John
4 - Director of Issuer
Holder: Ofra Aslan (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,900
+49,000 vol $0.10 each |
581,720 | |
| Filed 2022-08-24 09:33 Tx date 2022-08-17 |
$LOVE
Cannara Biotech Inc. |
Olds, Donald John
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,250
+50,000 vol $0.105 each |
562,000 | |
| Filed 2022-08-16 19:09 Tx date 2022-08-12 |
$LOVE
Cannara Biotech Inc. |
Olds, Donald John
4 - Director of Issuer
Holder: Ofra Aslan (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$150.00
+1,500 vol $0.10 each |
532,720 | |
| Filed 2022-08-11 08:44 Tx date 2022-08-08 |
$LOVE
Cannara Biotech Inc. |
Olds, Donald John
4 - Director of Issuer
Holder: Ofra Aslan (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$900.00
+9,000 vol $0.10 each |
531,220 | |
| Filed 2022-08-08 11:58 Tx date 2022-08-08 |
$LOVE
Cannara Biotech Inc. |
Olds, Donald John
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,750
+100,000 vol $0.1075 each |
512,000 | |
| Filed 2022-08-06 08:38 Tx date 2022-08-03 |
$LOVE
Cannara Biotech Inc. |
Olds, Donald John
4 - Director of Issuer
Holder: Ofra Aslan (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$20,000
+200,000 vol $0.10 each |
522,220 | |
| Filed 2022-05-25 14:22 Tx date 2022-05-24 |
$LOVE
Cannara Biotech Inc. |
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$24,200
+220,000 vol $0.11 each |
1,870,950 | |
| Filed 2022-05-10 12:55 Tx date 2022-05-10 |
$LOVE
Cannara Biotech Inc. |
Olds, Donald John
4 - Director of Issuer
Holder: Ofra Aslan (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$24,000
+200,000 vol $0.12 each |
322,220 | |
| Filed 2022-05-06 23:23 Tx date 2022-05-04 |
$LOVE
Cannara Biotech Inc. |
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$16,500
+150,000 vol $0.11 each |
1,650,950 | |
| Filed 2022-02-28 10:52 Tx date 2022-02-23 |
$LOVE
Cannara Biotech Inc. |
Olds, Donald John
4 - Director of Issuer
Holder: Ofra Aslan (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,150
+10,000 vol $0.115 each |
122,220 | |
| Filed 2022-02-10 16:34 Tx date 2022-02-10 |
$LOVE
Cannara Biotech Inc. |
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,875
+47,000 vol $0.125 each |
1,500,950 | |
| Filed 2022-01-27 14:49 Tx date 2022-01-27 |
$LOVE
Cannara Biotech Inc. |
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$33,280
+256,000 vol $0.13 each |
1,453,950 | |
| Filed 2022-01-27 11:45 Tx date 2022-01-26 |
$LOVE
Cannara Biotech Inc. |
Olds, Donald John
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,725
+35,000 vol $0.135 each |
412,000 | |
| Filed 2022-01-17 07:52 Tx date 2021-12-07 |
$LOVE
Cannara Biotech Inc. |
Dupuis, Nicolas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,000,000 vol |
1,150,000 | |
| Filed 2022-01-17 07:41 Tx date 2021-07-27 |
$LOVE
Cannara Biotech Inc. |
Dupuis, Nicolas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
150,000 | ||
| Filed 2022-01-12 10:45 Tx date 2021-12-07 |
$LOVE
Cannara Biotech Inc. |
Manouk, Anthony
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$180,000
+1,000,000 vol $0.18 each |
1,500,000 | |
| Filed 2022-01-10 22:29 Tx date 2021-12-07 |
$LOVE
Cannara Biotech Inc. |
Sherman, Brian
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,000,000 vol |
1,000,000 | |
| Filed 2022-01-10 22:19 Tx date 2021-10-04 |
$LOVE
Cannara Biotech Inc. |
Sherman, Brian
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-12-13 15:31 Tx date 2021-12-07 |
$LOVE
Cannara Biotech Inc. |
Kay, Jack M.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$9,000
+50,000 vol $0.18 each |
150,000 | |
| Filed 2021-12-13 13:06 Tx date 2021-12-07 |
$LOVE
Cannara Biotech Inc. |
Abitbol, David
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$180,000
+1,000,000 vol $0.18 each |
1,500,000 | |
| Filed 2021-12-13 12:57 Tx date 2021-02-01 |
$LOVE
Cannara Biotech Inc. |
Abitbol, David
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$90,000
+500,000 vol $0.18 each |
500,000 | |
| Filed 2021-12-13 12:51 Tx date 2020-12-22 |
$LOVE
Cannara Biotech Inc. |
Abitbol, David
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-12-13 07:57 Tx date 2021-12-07 |
$LOVE
Cannara Biotech Inc. |
Olds, Donald John
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$22,500
+125,000 vol $0.18 each |
375,000 | |
| Filed 2021-12-13 07:53 Tx date 2020-11-10 |
$LOVE
Cannara Biotech Inc. |
Olds, Donald John
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
250,000 | ||
| Filed 2021-12-11 12:12 Tx date 2020-05-15 |
$LOVE
Cannara Biotech Inc. |
Durocher, Mary
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
200,000 | ||
| Filed 2021-12-10 16:49 Tx date 2021-07-27 |
$LOVE
Cannara Biotech Inc. |
Krivorot, Avi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
$36,000
+200,000 vol $0.18 each |
200,000 | |
| Filed 2021-12-10 16:02 Tx date 2021-04-01 |
$LOVE
Cannara Biotech Inc. |
Krivorot, Avi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-12-10 16:01 Tx date 2020-03-25 |
$LOVE
Cannara Biotech Inc. |
Krivorot, Avi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,000
+10,000 vol $0.70 each |
10,000 | |
| Filed 2021-12-10 15:47 Tx date 2021-05-28 |
$LOVE
Cannara Biotech Inc. |
Krivorot, Avi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,050
+7,500 vol $0.14 each |
462,500 | |
| Filed 2021-12-10 15:46 Tx date 2021-05-28 |
$LOVE
Cannara Biotech Inc. |
Krivorot, Avi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,125
+75,000 vol $0.135 each |
455,000 | |
| Filed 2021-12-10 15:46 Tx date 2021-05-26 |
$LOVE
Cannara Biotech Inc. |
Krivorot, Avi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,400
+80,000 vol $0.13 each |
380,000 | |
| Filed 2021-12-10 15:45 Tx date 2021-05-26 |
$LOVE
Cannara Biotech Inc. |
Krivorot, Avi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,125
+75,000 vol $0.135 each |
300,000 | |
| Filed 2021-12-10 15:45 Tx date 2021-05-25 |
$LOVE
Cannara Biotech Inc. |
Krivorot, Avi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,125
+75,000 vol $0.135 each |
225,000 | |
| Filed 2021-12-10 15:44 Tx date 2021-05-21 |
$LOVE
Cannara Biotech Inc. |
Krivorot, Avi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,125
+75,000 vol $0.135 each |
150,000 | |
| Filed 2021-12-10 15:44 Tx date 2021-05-20 |
$LOVE
Cannara Biotech Inc. |
Krivorot, Avi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,125
+75,000 vol $0.135 each |
75,000 | |
| Filed 2021-12-10 15:37 Tx date 2021-04-01 |
$LOVE
Cannara Biotech Inc. |
Krivorot, Avi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-12-10 14:15 Tx date 2021-12-07 |
$LOVE
Cannara Biotech Inc. |
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$450,000
+2,500,000 vol $0.18 each |
6,000,000 | |
| Filed 2021-12-10 14:00 Tx date 2021-12-07 |
$LOVE
Cannara Biotech Inc. |
Follain, Noemi
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$180,000
+1,000,000 vol $0.18 each |
1,500,000 | |
| Filed 2021-12-09 17:04 Tx date 2021-06-21 |
$LOVE
Cannara Biotech Inc. |
Stern, Derek Elan
4 - Director of Issuer
Holder: Olymbec Investments Inc (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$23,907,968
+153,650,184 vol $0.1556 each |
163,650,184 | |
| Filed 2021-12-09 17:03 Tx date 2021-06-21 |
$LOVE
Cannara Biotech Inc. |
Stern, Derek Elan
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$23,907,968
+153,650,184 vol $0.1556 each |
||
| Filed 2021-12-09 16:50 Tx date 2021-06-21 |
$LOVE
Cannara Biotech Inc. |
Stern, Derek Elan
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$23,907,968
+153,650,184 vol $0.1556 each |
163,650,184 | |
| Filed 2021-12-09 16:50 Tx date 2021-06-21 |
$LOVE
Cannara Biotech Inc. |
Stern, Derek Elan
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$23,907,968
+153,650,184 vol $0.1556 each |
||
| Filed 2021-12-09 16:48 Tx date 2018-12-31 |
$LOVE
Cannara Biotech Inc. |
Stern, Derek Elan
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
10,000,000 | ||
| Filed 2021-12-09 16:46 Tx date 2020-02-19 |
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) |
Stern, Derek Elan
4 - Director of Issuer
Holder: Olymbec Investments Inc (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$4,000,198
+43,909,972 vol $0.0911 each |
||
| Filed 2021-12-09 16:45 Tx date 2021-06-21 |
$LOVE
Cannara Biotech Inc. |
Stern, Derek Elan
4 - Director of Issuer
Holder: Olymbec Investments Inc (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$19,299,999
+107,222,222 vol $0.18 each |
||
| Filed 2021-12-09 16:45 Tx date 2018-12-31 |
$LOVE
Cannara Biotech Inc. |
Stern, Derek Elan
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-12-09 16:44 Tx date 2020-02-19 |
$LOVE
Cannara Biotech Inc. |
Stern, Derek Elan
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$4,000,198
+43,909,972 vol $0.0911 each |
||
| Filed 2021-12-09 16:40 Tx date 2020-07-06 |
$LOVE
Cannara Biotech Inc. |
Stern, Derek Elan
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$251,799
+2,517,990 vol $0.10 each |
||
| Filed 2021-12-09 16:27 Tx date 2021-06-21 |
$LOVE
Cannara Biotech Inc. |
Stern, Richard
6 - Director or Senior Officer of 10% Security Holder
Holder: Olymbec Investments Inc (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
163,650,184 | ||
| Filed 2021-12-09 16:16 Tx date 2021-06-21 |
$LOVE
Cannara Biotech Inc. |
Stern, Derek Elan
4 - Director of Issuer
Holder: Olymbec Investments Inc (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$19,299,999
+107,222,222 vol $0.18 each |
||
| Filed 2021-12-09 16:11 Tx date 2021-06-21 |
$LOVE
Cannara Biotech Inc. |
Stern, Derek Elan
4 - Director of Issuer
Holder: Olymbec Investments Inc (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$19,299,999
+107,222,222 vol $0.18 each |
||
| Filed 2021-12-09 15:58 Tx date 2021-06-21 |
$LOVE
Cannara Biotech Inc. |
Stern, Derek Elan
4 - Director of Issuer
Holder: Olymbec Investments Inc (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$19,299,999
+107,222,222 vol $0.18 each |
||
| Filed 2021-12-09 15:58 Tx date 2021-06-21 |
$LOVE
Cannara Biotech Inc. |
Stern, Derek Elan
4 - Director of Issuer
Holder: Olymbec Investments Inc (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$19,299,999
+107,222,222 vol $0.18 each |
161,132,194 | |
| Filed 2021-12-09 15:50 Tx date 2020-02-19 |
$LOVE
Cannara Biotech Inc. |
Stern, Derek Elan
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$4,000,198
+43,909,972 vol $0.0911 each |
||
| Filed 2021-12-09 15:50 Tx date 2020-02-19 |
$LOVE
Cannara Biotech Inc. |
Stern, Derek Elan
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$4,000,198
+43,909,972 vol $0.0911 each |
53,909,972 | |
| Filed 2021-12-09 15:47 Tx date 2020-07-06 |
$LOVE
Cannara Biotech Inc. |
Stern, Derek Elan
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$251,799
+2,517,990 vol $0.10 each |
||
| Filed 2021-12-09 15:47 Tx date 2020-07-06 |
$LOVE
Cannara Biotech Inc. |
Stern, Derek Elan
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$251,799
+2,517,990 vol $0.10 each |
56,427,962 | |
| Filed 2021-12-09 15:35 Tx date 2018-12-31 |
$LOVE
Cannara Biotech Inc. |
Stern, Derek Elan
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-12-09 15:35 Tx date 2018-12-31 |
$LOVE
Cannara Biotech Inc. |
Stern, Derek Elan
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
10,000,000 | ||
| Filed 2021-12-09 15:27 Tx date 2020-02-19 |
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) |
Stern, Derek Elan
4 - Director of Issuer
Holder: Olymbec Investments Inc (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$4,000,198
+43,909,972 vol $0.0911 each |
||
| Filed 2021-12-09 15:27 Tx date 2020-02-19 |
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) |
Stern, Derek Elan
4 - Director of Issuer
Holder: Olymbec Investments Inc (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$4,000,198
+43,909,972 vol $0.0911 each |
53,909,972 | |
| Filed 2021-07-02 16:47 Tx date 2021-06-21 |
$LOVE
Cannara Biotech Inc. |
Stern, Derek Elan
4 - Director of Issuer
Holder: Olymbec Investments Inc (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$19,299,999
+107,222,222 vol $0.18 each |
||
| Filed 2021-07-02 16:47 Tx date 2021-06-21 |
$LOVE
Cannara Biotech Inc. |
Stern, Derek Elan
4 - Director of Issuer
Holder: Olymbec Investments Inc (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$19,299,999
+107,222,222 vol $0.18 each |
||
| Filed 2021-07-02 16:01 Tx date 2021-06-21 |
$LOVE
Cannara Biotech Inc. |
Stern, Richard
6 - Director or Senior Officer of 10% Security Holder
Holder: Olymbec Investments Inc (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-02-21 12:44 Tx date 2020-02-19 |
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) |
Stern, Derek Elan
4 - Director of Issuer
Holder: Olymbec Investments Inc (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$4,000,152
+43,909,472 vol $0.0911 each |
||
| Filed 2020-02-21 12:44 Tx date 2020-02-19 |
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) |
Stern, Derek Elan
4 - Director of Issuer
Holder: Olymbec Investments Inc (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$4,000,152
+43,909,472 vol $0.0911 each |
||
| Filed 2021-08-27 13:04 Tx date 2021-08-27 |
$LOVE
Cannara Biotech Inc. |
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,405
+57,000 vol $0.165 each |
1,197,950 | |
| Filed 2021-08-27 13:03 Tx date 2021-08-24 |
$LOVE
Cannara Biotech Inc. |
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,220
+68,000 vol $0.165 each |
1,140,950 | |
| Filed 2021-08-23 09:36 Tx date 2021-08-10 |
$LOVE
Cannara Biotech Inc. |
Olds, Donald John
4 - Director of Issuer
Holder: Ofra Aslan (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$990.00
+6,000 vol $0.165 each |
86,000 | |
| Filed 2021-08-23 09:22 Tx date 2021-08-20 |
$LOVE
Cannara Biotech Inc. |
Olds, Donald John
4 - Director of Issuer
Holder: Ofra Aslan (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,457
+26,220 vol $0.17 each |
112,220 | |
| Filed 2021-08-05 11:18 Tx date 2021-08-05 |
$LOVE
Cannara Biotech Inc. |
Olds, Donald John
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$25,500
+150,000 vol $0.17 each |
377,000 | |
| Filed 2021-07-09 14:18 Tx date 2021-06-21 |
$LOVE
Cannara Biotech Inc. |
Olymbec Investments Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
161,131,694 | ||
| Filed 2021-07-02 16:47 Tx date 2021-06-21 |
$LOVE
Cannara Biotech Inc. |
Stern, Derek Elan
4 - Director of Issuer
Holder: Olymbec Investments Inc (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$19,299,999
+107,222,222 vol $0.18 each |
161,131,694 | |
| Filed 2021-07-02 16:01 Tx date 2021-06-21 |
$LOVE
Cannara Biotech Inc. |
Stern, Richard
6 - Director or Senior Officer of 10% Security Holder
Holder: Olymbec Investments Inc (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
161,131,694 | ||
| Filed 2021-05-17 15:39 Tx date 2021-05-14 |
$LOVE
Cannara Biotech Inc. |
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$49,000
+350,000 vol $0.14 each |
1,072,950 | |
| Filed 2021-05-06 11:25 Tx date 2021-05-06 |
$LOVE
Cannara Biotech Inc. |
Olds, Donald John
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,890
+82,000 vol $0.145 each |
227,000 | |
| Filed 2021-05-06 11:24 Tx date 2021-05-05 |
$LOVE
Cannara Biotech Inc. |
Olds, Donald John
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,610
+18,000 vol $0.145 each |
145,000 | |
| Filed 2021-04-14 15:01 Tx date 2018-12-31 |
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) |
Krivorot, Zohar
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Javaa Private Equity Inc. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
231,832,194 | ||
| Filed 2020-08-20 18:10 Tx date 2018-12-31 |
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) |
Krivorot, Zohar
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Javaa Private Equity Inc. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-01-09 12:17 Tx date 2018-12-31 |
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) |
Krivorot, Zohar
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Javaa Private Equity Inc. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-03-05 15:37 Tx date 2020-05-01 |
$LOVE
Cannara Biotech Inc. |
Manouk, Anthony
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
500,000 | ||
| Filed 2021-02-26 07:52 Tx date 2020-12-15 |
$LOVE
Cannara Biotech Inc. |
Follain, Noemi
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$45,000
+250,000 vol $0.18 each |
500,000 | |
| Filed 2021-02-26 07:50 Tx date 2020-11-09 |
$LOVE
Cannara Biotech Inc. |
Follain, Noemi
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
250,000 | ||
| Filed 2021-02-24 10:35 Tx date 2021-02-23 |
$LOVE
Cannara Biotech Inc. |
Olds, Donald John
4 - Director of Issuer
Holder: Ofra Aslan (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,400
+60,000 vol $0.14 each |
80,000 | |
| Filed 2021-02-08 08:55 Tx date 2021-02-04 |
$LOVE
Cannara Biotech Inc. |
Olds, Donald John
4 - Director of Issuer
Holder: Ofra Aslan (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,400
+20,000 vol $0.12 each |
20,000 | |
| Filed 2021-02-08 08:54 Tx date 2020-11-10 |
$LOVE
Cannara Biotech Inc. |
Olds, Donald John
4 - Director of Issuer
Holder: Ofra Aslan (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-02-08 08:54 Tx date 2021-02-04 |
$LOVE
Cannara Biotech Inc. |
Olds, Donald John
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,605
+127,000 vol $0.115 each |
127,000 | |
| Filed 2021-02-08 08:52 Tx date 2020-11-10 |
$LOVE
Cannara Biotech Inc. |
Olds, Donald John
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-11-10 23:15 Tx date 2020-11-10 |
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) |
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
3,500,000 | ||
| Filed 2020-11-10 22:46 Tx date 2020-11-10 |
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) |
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
722,950 | ||
| Filed 2020-10-19 16:58 Tx date 2020-10-15 |
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) |
Ryer, Lennie
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$12,750
+150,000 vol $0.085 each |
591,078 | |
| Filed 2020-10-02 14:08 Tx date 2020-10-01 |
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) |
Ryer, Lennie
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$680.00
+8,000 vol $0.085 each |
441,078 | |
| Filed 2020-09-24 13:42 Tx date 2020-09-23 |
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) |
Ryer, Lennie
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,015
+59,000 vol $0.085 each |
433,078 | |
| Filed 2020-09-17 10:47 Tx date 2020-09-14 |
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) |
Ryer, Lennie
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,360
+51,300 vol $0.085 each |
374,078 | |
| Filed 2020-08-20 18:10 Tx date 2018-12-31 |
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) |
Krivorot, Zohar
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Javaa Private Equity Inc. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
231,761,250 | ||
| Filed 2019-01-09 12:17 Tx date 2018-12-31 |
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) |
Krivorot, Zohar
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Javaa Private Equity Inc. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-02-28 11:59 Tx date 2019-04-25 |
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) |
Kay, Jack M.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$18,000
+100,000 vol $0.18 each |
100,000 | |
| Filed 2020-02-28 11:58 Tx date 2019-04-08 |
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) |
Kay, Jack M.
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-02-28 11:58 Tx date 2020-02-04 |
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) |
Kay, Jack M.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$155,000
+1,000,000 vol $0.155 each |
2,190,000 | |
| Filed 2020-02-28 11:55 Tx date 2020-02-03 |
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) |
Kay, Jack M.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$29,450
+190,000 vol $0.155 each |
1,190,000 | |
| Filed 2020-02-28 11:54 Tx date 2020-02-03 |
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) |
Kay, Jack M.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$165,000
+1,000,000 vol $0.165 each |
1,000,000 | |
| Filed 2020-02-28 11:54 Tx date 2019-12-27 |
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) |
Kay, Jack M.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-115,862.50
-1,007,500 vol $0.115 each |
0 | |
| Filed 2020-02-28 11:53 Tx date 2019-12-24 |
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) |
Kay, Jack M.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-3,720
-31,000 vol $0.12 each |
1,007,500 | |
| Filed 2020-02-28 11:53 Tx date 2019-12-23 |
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) |
Kay, Jack M.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-8,280
-69,000 vol $0.12 each |
1,038,500 | |
| Filed 2020-02-28 11:52 Tx date 2019-12-20 |
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) |
Kay, Jack M.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-43,500
-362,500 vol $0.12 each |
1,107,500 | |
| Filed 2020-02-28 11:52 Tx date 2019-12-19 |
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) |
Kay, Jack M.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-164,920
-1,330,000 vol $0.124 each |
1,470,000 | |
| Filed 2020-02-28 11:51 Tx date 2019-04-08 |
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) |
Kay, Jack M.
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
2,800,000 | ||
| Filed 2020-02-21 12:44 Tx date 2020-02-19 |
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) |
Stern, Derek Elan
4 - Director of Issuer
Holder: Olymbec Investments Inc (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$4,000,152
+43,909,472 vol $0.0911 each |
53,909,472 | |
| Filed 2020-02-20 15:22 Tx date 2020-02-19 |
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) |
Laxer, Barnett
5 - Senior Officer of Issuer
Holder: Radical Design Ltd. (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$1,250,047
+13,721,711 vol $0.0911 each |
13,721,711 | |
| Filed 2020-02-20 15:19 Tx date 2019-08-14 |
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) |
Laxer, Barnett
5 - Senior Officer of Issuer
Holder: Radical Design Ltd. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-02-20 15:16 Tx date 2020-02-19 |
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) |
Krivorot, Zohar
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Javaa Private Equity Inc. (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$743,524
+8,161,626 vol $0.0911 each |
242,167,820 | |
| Filed 2020-02-07 12:00 Tx date 2019-08-14 |
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) |
Laxer, Barnett
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
15,000,000 | ||
| Filed 2020-02-07 11:58 Tx date 2019-08-14 |
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) |
Laxer, Barnett
5 - Senior Officer of Issuer
Holder: JCJ Family Trust (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
12,000,000 | ||
| Filed 2020-01-21 13:28 Tx date 2020-01-16 |
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) |
Abramovitch, David
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$27,000
+150,000 vol $0.18 each |
150,000 | |
| Filed 2020-01-21 13:27 Tx date 2020-01-16 |
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) |
Abramovitch, David
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-08-15 16:42 Tx date 2019-08-15 |
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) |
Krivorot, Zohar
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Javaa Private Equity Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,185
+27,000 vol $0.155 each |
234,006,194 | |
| Filed 2019-08-15 16:41 Tx date 2019-08-15 |
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) |
Krivorot, Zohar
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Javaa Private Equity Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,729
+98,000 vol $0.1503 each |
233,979,194 | |
| Filed 2019-08-09 15:31 Tx date 2019-08-09 |
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) |
Krivorot, Zohar
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Javaa Private Equity Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$62,202
+422,000 vol $0.1474 each |
233,881,194 | |
| Filed 2019-08-08 11:21 Tx date 2019-08-07 |
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) |
Krivorot, Zohar
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Javaa Private Equity Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$47,299
+345,000 vol $0.1371 each |
233,459,194 | |
| Filed 2019-03-14 Tx date 2019-03-13 |
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) |
Ryer, Lennie
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,100
+45,000 vol $0.18 each |
322,778 | |
| Filed 2019-03-14 Tx date 2019-03-13 |
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) |
Krivorot, Zohar
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Javaa Private Equity Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$238,323
+1,282,000 vol $0.1859 each |
233,114,194 | |
| Filed 2019-01-31 Tx date 2019-01-30 |
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) |
Carroll, Donal
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-98,500
-500,000 vol $0.197 each |
0 | |
| Filed 2019-01-14 Tx date 2018-12-31 |
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) |
Bokhari, Raza
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,807,361 | ||
| Filed 2019-01-11 Tx date 2018-12-31 |
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) |
Durkacz, Anthony John
3 - 10% Security Holder of Issuer
Holder: Fortius Research and Trading Corp. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
4,000,000 | ||
| Filed 2019-01-11 Tx date 2018-12-31 |
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) |
Durkacz, Anthony John
3 - 10% Security Holder of Issuer
Holder: First Republic Capital Corp. (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
4,042,945 | ||
| Filed 2019-01-11 Tx date 2018-12-31 |
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) |
Durkacz, Anthony John
3 - 10% Security Holder of Issuer
Holder: First Republic Capital Corp. (Indirect Ownership)
|
Options
00 - Opening Balance-Initial SEDI Report
|
1,341,877 |